Gainers

• Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session.
• GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap stands at $1.8 million.
• Pulmonx (NASDAQ:LUNG) shares moved upwards by 32.07% to $1.65. The company's market cap stands at $52.7 million. The company's, Q2 earnings came out yesterday.
• China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 29.23% to $0.07. The market value of their outstanding shares is at $2.0 million.
• Corcept Therapeutics (NASDAQ:CORT) shares moved upwards by 27.53% to $118.55. The company's market cap stands at $9.9 billion. As per the news, the Q2 earnings report came out yesterday.
• Bausch Health Companies (NYSE:BHC) stock rose 26.28% to $5.91. The market value of their outstanding shares is at $1.7 billion. The company's, Q2 earnings came out yesterday.

Losers

• Capricor Therapeutics (NASDAQ:CAPR) shares decreased by 40.3% to $3.92 during Thursday's regular session.
• Inovio Pharmaceuticals (NASDAQ:INO) stock decreased by 37.5% to $0.65. The company's market cap stands at $85.5 million.
• Alnylam Pharmaceuticals (NASDAQ:ALNY) stock decreased by 29.69% to $201.53. The market value of their outstanding shares is at $38.2 billion. As per the press release, Q2 earnings came out today.
• Teladoc Health (NYSE:TDOC) shares fell 27.1% to $6.69. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q2 earnings report came out yesterday.
• Autonomix Medical (NASDAQ:AMIX) shares fell 23.75% to $3.48. The company's market cap stands at $2.4 million.
• Healthcare Triangle (NASDAQ:HCTI) shares declined by 22.44% to $1.21. The market value of their outstanding shares is at $3.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.